Douglas J. Manion Aclaris Therapeutics, Inc. (ACRS) insider trading activity

Douglas J. Manion is Pres and CEO of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 41,813 shares of ACRS, which is worth approximately $75,681. The most recent transaction as insider was on Jan 01, 2024, when has been sold 9,125 shares (Common Stock) at a price of $1.05 per share, resulting in proceeds of $9,581. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.8K

0% 3M change

74.67% 12M change

Total Value Held $75,681

Douglas J. Manion Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2024	SELL Payment of exercise price or tax liability	$9,581 $1.05 p/Share	9,125 Reduced 17.91%	41,813 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	27,000 Added 34.64%	50,938 Common Stock
Aug 01 2023	SELL Payment of exercise price or tax liability	$43,526 $9.81 p/Share	4,437 Reduced 15.64%	23,938 Common Stock
Aug 01 2023	BUY Exercise of conversion of derivative security	-	15,575 Added 35.44%	28,375 Common Stock
Mar 17 2023	BUY Open market or private purchase	$49,518 $7.86 p/Share	6,300 Added 32.98%	12,800 Common Stock
Mar 09 2023	BUY Open market or private purchase	$50,310 $7.74 p/Share	6,500 Added 50.0%	6,500 Common Stock

Also insider at

ARNA

ARENA PHARMACEUTICALS INC Healthcare

EVP Research & Development

DJM

Douglas J. Manion

Pres and CEO

Wayne, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Value

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aclaris Therapeutics, Inc.

Track Activities on ACRS

Account